Determinants of hepatitis B vaccine uptake among pregnant Chinese women in Hong Kong

International Journal of Gynecology and Obstetrics

Volumn 106, Issue 3, 2009, Pages 232-235

  Chan, Oi Ka ^a   Suen, Stephen Sik Hung ^a   Lao, Terence Tzu Hsi ^a   Leung, Viola Kit Tong ^a   Yeung, Sik Wing ^a   Leung, Tak Yeung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatitis B; Pregnant women; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ARTICLE; AWARENESS; EDUCATIONAL STATUS; EMPLOYMENT; FACTORIAL ANALYSIS; FEMALE; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH PROMOTION; HEPATITIS B; HUMAN; INCOME; OUTPATIENT DEPARTMENT; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; VACCINATION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HEPATITIS B VACCINES; HONG KONG; HUMANS; IMMUNIZATION PROGRAMS; MEDICATION ADHERENCE; PREGNANCY; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 68349150942     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.03.043     Document Type: Article

References (22)

1. Beasley R.P., Hwang L.Y., Lin C.C., and Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2 8256 (1981) 1129-1133
2. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 10 (1988) 1942-1956
3. Beasley R.P. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma - epidemiologic consideration. Hepatology 2 (1982) 21S-26S
4. Kwan L.C., Ho Y.Y., and Lee S.S. The declining HBsAg carriage rate in pregnant women in Hong Kong. Epidemiol Infect 119 2 (1997) 281-283
5. Department of Health, Hong Kong. Surveillance of viral hepatitis in Hong Kong-2006 update report. Available from http://www.info.gov.hk/hepatitis/doc/hepsurv06.pdf. Published December 2007. Accessed 29 December 2008.
6. Moyes C., and Milne A. Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children. N Z Med J 101 843 (1988) 162-164
7. Poovorawan Y., Sanpavat S., Pongpunlert W., Chumdermpadetsuk S., Sentrakul P., and Safary A. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 261 22 (1989) 3278-3281
8. Poovorawan Y., Sanpavat S., Pongpunglert W., Chumdermpadetsuk S., Sentrakul P., Vandepapelière P., et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. Pediatr Infect Dis J 11 10 (1992) 816-821
9. Lai C.L., Wong B.C., Yeoh E.K., Lim W.L., Chang W.K., and Lin H.J. Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: immunogenicity and anamnestic responses. Hepatology 18 4 (1993) 763-767
10. Wainwright R.B., Bulkow L.R., Parkinson A.J., Zanis C., and McMahon B.J. Protection provided by hepatitis B vaccine in a Yupik Eskimo population-results of a 10-year study. J Infect Dis 175 3 (1997) 674-677
11. Ni Y.H., Chang M.H., Huang L.M., Chen H.L., Hsu H.Y., Chiu T.Y., et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135 9 (2001) 796-800
12. Harpaz R., McMahon B.J., Margolis H.S., Shapiro C.N., Havron D., Carpenter G., et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis 181 2 (2000) 413-418
13. Poovorawan Y., Theamboonlers A., Vimolket T., Sinlaparatsamee S., Chaiear K., Siraprapasiri T., et al. Impact of hepatitis B immunisation as part of the EPI. Vaccine 19 7-8 (2000) 943-949
14. Wallace L.A., Bramley J.C., Ahmed S., Duff R., Hutchinson S.J., Carman W.F., et al. Determinants of universal adolescent hepatitis B vaccine uptake. Arch Dis Child 89 11 (2004) 1041-1042
15. Baars J.E., Boon B., Garretsen H., and van de Mheen D. Vaccination uptake and awareness of a free hepatitis B vaccination program among female commercial sex workers. Womens Health Issues 19 1 (2009) 61-69
16. McGregor J., Marks P.J., Hayward A., Bell Y., and Slack R.C. Factors influencing hepatitis B vaccine uptake in injecting drug users. J Public Health Med 25 2 (2003) 165-170
17. Macdonald V., Dore G.J., Amin J., and van Beek I. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health 4 1 (2007) 27-30
18. Sofola O.O., and Uti O.G. Hepatitis B virus infection and prevention in the dental clinic: knowledge and factors determining vaccine uptake in a Nigerian dental teaching hospital. Nig Q J Hosp Med 18 3 (2008) 145-148
19. Zimet G.D., Perkins S.M., Winston Y., and Kee R. Predictors of first and second dose acceptance of hepatitis B vaccine among STD clinic patients. Int J STD AIDS 19 4 (2008) 246-250
20. Expanded programme on immunization. Global advisory group-Part I. Wkly Epidemiol Rec 67 3 (1992) 11-15
21. Goldstein S.T., Cassidy W.M., Hodgson W., and Mahoney F.J. Factors associated with student participation in a school-based hepatitis B immunization program. J Sch Health 71 5 (2001) 184-187
22. Census and Statistics Department. The Government of the Hong Kong Special Administrative Region. Hong Kong 2006 Population By-census Thematic Report: Persons from the Mainland Having Resided in Hong Kong for Less Than 7 Years. Available at: http://www.censtatd.gov.hk/products_and_services/products/publications/statistical_report/population_and_vital_events/index_cd_B1120049_dt_detail.jsp. Release date December 14, 2007.